insights_auto
Why is ORX up 3.05%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK 14.18
arrow_upward
+3.05%(+0.42) 1D
Oct 1, 12:56:07 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 14.72
High
SEK 14.72
Low
SEK 13.74
Mkt. cap
498.10M
Avg. vol.
41.58K
Volume
24.00K
P/E ratio
0.60
52-wk high
SEK 43.40
52-wk low
SEK 12.20
EPS
SEK 23.61
Shares outstanding
35.13M
No. of employees
61
Open
SEK 14.72
High
SEK 14.72
Low
SEK 13.74
Mkt. cap
498.10M
Avg. vol.
41.58K
Volume
24.00K
P/E ratio
0.60
52-wk high
SEK 43.40
52-wk low
SEK 12.20
EPS
SEK 23.61
Shares outstanding
35.13M
No. of employees
61
News stories
From web sources and news partners
MedWatch
·
1 day ago
Orexo resubmits US approval application for opioid overdose drug
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB